ES2156533B1 - Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas. - Google Patents

Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas.

Info

Publication number
ES2156533B1
ES2156533B1 ES9900217A ES9900217A ES2156533B1 ES 2156533 B1 ES2156533 B1 ES 2156533B1 ES 9900217 A ES9900217 A ES 9900217A ES 9900217 A ES9900217 A ES 9900217A ES 2156533 B1 ES2156533 B1 ES 2156533B1
Authority
ES
Spain
Prior art keywords
inhibitor
sintetasas
adenylphosphate
aminoacil
arn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9900217A
Other languages
English (en)
Other versions
ES2156533A1 (es
Inventor
Steve W Elson
Monedero Emilio Diez
Jose Maria Sanchez-Puelles
Rodriguez Juan Antonio Hueso
Jadu Manuel Valmaseda
Rodriguez Francisco J Colilla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haleon Alcala SA
Original Assignee
SmithKline Beecham SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham SA filed Critical SmithKline Beecham SA
Priority to ES9900217A priority Critical patent/ES2156533B1/es
Publication of ES2156533A1 publication Critical patent/ES2156533A1/es
Application granted granted Critical
Publication of ES2156533B1 publication Critical patent/ES2156533B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Nuevo derivado de adenilfosfato como inhibidor de aminoacil ARN- t-sintetasas. La invención describe el nuevo compuesto de la fórmula (I) y su uso como un inhibidor de la enzima bacteriana metionil-tRNA sintetasa. El compuesto es producido por la fermentación del actinomiceto Streptomyces platensis. El compuesto es útil en el tratamiento de infecciones bacterianas. **FORMULA 01**
ES9900217A 1999-02-03 1999-02-03 Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas. Expired - Fee Related ES2156533B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9900217A ES2156533B1 (es) 1999-02-03 1999-02-03 Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9900217A ES2156533B1 (es) 1999-02-03 1999-02-03 Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas.

Publications (2)

Publication Number Publication Date
ES2156533A1 ES2156533A1 (es) 2001-06-16
ES2156533B1 true ES2156533B1 (es) 2002-02-01

Family

ID=8307176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9900217A Expired - Fee Related ES2156533B1 (es) 1999-02-03 1999-02-03 Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas.

Country Status (1)

Country Link
ES (1) ES2156533B1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421687A (en) * 1981-09-26 1983-12-20 Takeda Chemical Industries, Limited Macbecin derivatives

Also Published As

Publication number Publication date
ES2156533A1 (es) 2001-06-16

Similar Documents

Publication Publication Date Title
BR0116216A (pt) Inibidores de girase e seus usos
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
DE602004030810D1 (de) Implantate mit befestigten silylierten therapeutischen mitteln
DE60215494D1 (de) Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel
MY129319A (en) Crystal forms of azithromycin
ECSP003699A (es) Inhibidores de fab i
AU2003291227A1 (en) Antibacterial agents
EP1171428A4 (en) FAB-I INHIBITORS
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
NZ510369A (en) Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
AU2003303956A1 (en) Antibacterial agents
ATE256677T1 (de) Inhibitoren der bakteriellen nad synthetase
SG152274A1 (en) Dalbavancin compositions for treatment of bacterial infections
ATE196735T1 (de) Neue antibiotika und ihre enthaltende antibiotische zusammensetzungen für die inhibition gram positiven bakterien und mykoplasmen.
SE0302129D0 (sv) Farmaceutiska kompositioner med antibiotisk aktivitet
UA83250C2 (ru) Применение тигециклина для лечения инфекций костей или костного мозга, инфекций суставов или тканей, окружающих сустав
ES2156533B1 (es) Nuevo derivado de adenilfosfato como inhibidor de aminoacil arn-t-sintetasas.
DK1618106T3 (da) Carbacephem beta-lactam antibiotika
ES2158769B1 (es) Nuevos derivados de altemicidina.
ES2158770B1 (es) Nuevos glicopeptidos.
DE69926722D1 (de) Azithromycin enthaltende Zusammensetzungen zur Kontrolle von Emesis bei Hunden
NZ511728A (en) Substances WK-5344A and WK-5344B obtained from microorganisms of the genus Streptomyces
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
ES2156703B1 (es) Derivados de benzopiranona como inhibidores de aminoacil arn-t- sintetasas.
ES2082806T3 (es) Derivados quimicos de los antibioticos alfa- y beta-ll-e19020.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010616

Kind code of ref document: A1

Effective date: 20010616

FD2A Announcement of lapse in spain

Effective date: 20180807